Portals for Prions?

Prion disorders riddle the mammalian brain with plaque and holes, the precise pattern and resulting symptoms--dementia, extreme fatigue, or loss of balance--depending on whether one is human, bovine, or ovine. The agent of such a transmissible spongiform encephalopathy (TSE) is an infectious form of prion protein, called PrP scrapie (PrPSc), named after the long-known sheep illness. In bovine spongiform encephalopathy (mad cow disease) and its human version, variant Creutzfeldt-Jakob disease (vC

Written byRicki Lewis
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Until now, most prion research explored brain tissue--the end point of infection. But a few investigators are seeking the site where prions pathogenesis begins. And their work is converging on a little-mentioned resident of the intestinal lining called an M cell.

M cells link the digestive and immune systems.1 They provide a portal for ingested bacteria and viruses to lymphoid tissue beneath the intestinal lining. "M cells sample antigens so that the body can mount an effective protective immune response," explains Marian Neutra, a professor of pediatrics at Harvard Medical School. But the M cell defense isn't foolproof. "Pathogens have evolved faster than us to exploit this antigen sampling mechanism," she adds. Certain bacteria and viruses usurp the M cell connection, and prions may do so too. Their passage to humans from tainted food-beef in the case of vCJD, and human flesh decades ago in kuru among the Foré people ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies